SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Struwe Weston B.)
 

Search: WFRF:(Struwe Weston B.) > Fc Gamma Receptor G...

  • Hayes, Jerrard M (author)

Fc Gamma Receptor Glycosylation Modulates the Binding of IgG Glycoforms : A Requirement for Stable Antibody Interactions

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • 2014-11-11
  • American Chemical Society (ACS),2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-237577
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-237577URI
  • https://doi.org/10.1021/pr500414qDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • FcγRs play a critical role in the immune response following recognition of invading particles and tumor associated antigens by circulating antibodies. In the present study we investigated the role of FcγR glycosylation in the IgG interaction and observed a stabilizing role for receptor N-glycans. We performed a complete glycan analysis of the recombinant FcγRs (FcγRIa, FcγRIIa, FcγRIIb, FcγRIIIaPhe158/Val158, and FcγRIIIb) expressed in human cells and demonstrate that receptor glycosylation is complex and varied between receptors. We used surface plasmon resonance to establish binding patterns between rituximab and all receptors. Complex binding was observed for FcγRIa and FcγRIIIa. The IgG-FcγR interaction was further investigated using a combination of kinetic experiments and enzymatically deglycosylated FcγRIa and FcγRIIIaPhe158/Val158 receptors in an attempt to determine the underlying binding mechanism. We observed that antibody binding levels decreased for deglycosylated receptors, and at the same time, binding kinetics were altered and showed a more rapid approach to steady state, followed by an increase in the antibody dissociation rate. Binding of rituximab to deglycosylated FcγRIIIaPhe158 was now consistent with a 1:1 binding mechanism, while binding of rituximab to FcγRIIIaVal158 remained heterogeneous. Kinetic data support a complex binding mechanism, involving heterogeneity in both antibody and receptor, where fucosylated and afucosylated antibody forms compete in receptor binding and in receptor molecules where heterogeneity in receptor glycosylation plays an important role. The exact nature of receptor glycans involved in IgG binding remains unclear and determination of rate and affinity constants are challenging. Here, the use of more extended competition experiments appear promising and suggest that it may be possible to determine dissociation rate constants for high affinity afucosylated antibodies without the need to purify or express such variants. The data described provide further insight into the complexity of the IgG-FcγR interaction and the influence of FcγR glycosylation.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Frostell, Asa (author)
  • Cosgrave, Eoin F J (author)
  • Struwe, Weston B (author)
  • Potter, Oscar (author)
  • Davey, Gavin P (author)
  • Karlsson, Robert (author)
  • Anneren, CeciliaGE Healthcare, Rapsgatan 23, SE-75184 Uppsala, Sweden(Swepub:uu)cecianne (author)
  • Rudd, Pauline M (author)
  • GE Healthcare, Rapsgatan 23, SE-75184 Uppsala, Sweden (creator_code:org_t)

Related titles

  • In:Journal of Proteome Research: American Chemical Society (ACS)13:12, s. 5471-54851535-38931535-3907

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view